With an annual growth rate in excess of 10%, the life sciences are one of the strongest industrial sectors in Switzerland. The research results and inventions generated by universities can make a major contribution to the progress in life sciences if they are transferred to industrial companies and developed into marketable products and services. In particular the establishment of new companies – spin-offs or start-ups – ensures that the results of research are turned into innovative medical products and that new jobs are created.
In 2009 Università della Svizzera italiana (USI) started to develop leading-edge comprehensive advanced programs – BioBusiness, MedTech Business, BioClub – to provide young life sciences companies with the theoretical and project-based practical skills needed to develop, fund and market biomedical innovations. These programs are now offered through the Center of Advanced Studies on Entrepreneurship in BioMedicine – CASE BioMed, an autonomous structure within the Faculty of Biomedical Sciences. In this way, CASE BioMed will also contribute to complete the scientific and biomedical education provided by the Faculty.